Amphomycin inhibits the incorporation of mannose and GlcNAc into lipid-linked saccharides by aorta extracts.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001011:Aorta / Q000378:metabolism*; D003864:Depression, Chemical; D004287:Dolichol Monophosphate Mannose / Q000378:metabolism; D006017:Glycolipids / Q000378:metabolism; D006023:Glycoproteins / Q000378:metabolism; D006155:Guanosine Diphosphate Mannose / Q000378:metabolism*; D066298:In Vitro Techniques; D055666:Lipopeptides; D009161:Mycobacterium / Q000378:metabolism; D009702:Nucleoside Diphosphate Sugars / Q000378:metabolism*; D009842:Oligopeptides / Q000494:pharmacology*; D011105:Polyisoprenyl Phosphate Sugars / Q000378:metabolism*; D013552:Swine; D014536:Uridine Diphosphate N-Acetylgalactosamine / Q000378:metabolism*; D014539:Uridine Diphosphate Sugars / Q000378:metabolism*
D000900:Anti-Bacterial Agents; D006017:Glycolipids; D006023:Glycoproteins; D055666:Lipopeptides; D009702:Nucleoside Diphosphate Sugars; D009842:Oligopeptides; D011105:Polyisoprenyl Phosphate Sugars; D014539:Uridine Diphosphate Sugars; D006155:Guanosine Diphosphate Mannose; C004423:amphomycin; D004287:Dolichol Monophosphate Mannose; D014536:Uridine Diphosphate N-Acetylgalactosamine